CGIX - TAP QLYS among premarket losers
Anchiano Therapeutics (ANCN) -28%.Pulmatrix (PULM) -21% on direct offering.United States Antimony (UAMY) -21% on direct offering.Cancer Genetics (CGIX) -21% on stock offering.BioHiTech Global (BHTG) -15%.Fluidigm (FLDM) -14% on Q4 earnings; inks distribution deal for Fluidigm CyTOF technology, panels and reagents to clinical labs in China.Tengasco (TGC) -13%.COMSovereign Holding (COMS) -12% on stock offering.Predictive Oncology (POAI) -10% on direct offering.Nano-X Imaging (NNOX) -10%.The OLB Group (OLB) -9%.Arcadia Biosciences (RKDA) -8%.American Resources (AREC) -8%.Mesa Air Group (MESA) -8% after striking deal to invest in Archer Aviation.Ayro (AYRO) -8%.Qualys (QLYS) -8% as full-year forecast falls flat.Kadmon Holdings (KDMN) -7% on convertible debt offering.Spirit Airlines (SAVE) -7% on Q4 earnings.Salarius Pharmaceuticals (SLRX) -7%.Enservco (ENSV) -6%.Torchlight Energy Resources (TRCH) -6%.Gamida Cell (GMDA) -5%.Dynatronics (DYNT) -5% on FQ2 earnings.Molson Coors Beverage (TAP) -5% after volume plummets in Europe.
For further details see:
TAP, QLYS among premarket losers